Aug 6, 2026 4:01 pm EDT Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
Jul 30, 2026 4:01 pm EDT Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
Jul 16, 2026 7:00 am EDT Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology
Jul 14, 2026 7:00 am EDT New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)
Jun 25, 2026 4:15 pm EDT Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Jun 23, 2026 9:57 pm EDT Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering